The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries Upon Outcomes of Chronic Periodontitis
ENURGISE
1 other identifier
interventional
108
3 countries
3
Brief Summary
The objective of this study is to determine whether enhanced micronutrient intake in the form of fruit, vegetable and berry juice powder (FVB) concentrate, improves clinical outcomes in chronic periodontitis patients prior to standard non-surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2010
CompletedFirst Posted
Study publicly available on registry
October 28, 2010
CompletedStudy Start
First participant enrolled
May 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2017
CompletedMarch 18, 2019
March 1, 2019
1 month
October 26, 2010
March 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in clinical parameters
The primary outcomes will be differences in the changes in the below parameters at 3-months post-supplementation between test and placebo groups: * % sites with marginal bleeding on probing (BOP) from baseline. * Probing pocket depth reductions (mm) from baseline (expressed as reductions in mean and also cumulative pocket depth).
3 months
Changes in clinical parameters
The primary outcomes will be differences in the changes in the parameters listed below at 6 months (3 months post supplementation + 3 months post treatment)in test and placebo groups % sites with marginal BOP from baseline. Probing pocket depth reductions (mm) from baseline (expressed as reductions in mean and also cumulative pocket depth).
6 months
Secondary Outcomes (2)
Clinical and biochemical changes
3 months
Clinical and biochemical changes
6 months
Study Arms (2)
Supplementation with non-active
PLACEBO COMPARATORSubjects will be supplemented with placebo capsules (3 capsules am \& 3 capsules pm)
Dietary supplementation with Juice plus+
ACTIVE COMPARATORSubjects will be supplemented with Juice plus+ capsules (3 capsules am \& 3 capsules pm)
Interventions
Subjects in active group will be supplemented with Juice plus+ capsules (3 in the morning and 3 in the evening, for 3 months)
Subjects will take non-active placebo capsules (3 in the morning and 3 in the evening, for 3 months)
Eligibility Criteria
You may qualify if:
- be aged 18 years old and over
- have a minimum of 20 teeth
- have chronic periodontitis
- be capable of giving informed consent themselves
You may not qualify if:
- Patients with aggressive disease
- Patients with physical or mental disability
- Pregnant women or those breastfeeding
- Patients whose medical history may place them at risk of complications from periodontal therapy (e.g. warfarinised Volunteers)
- Patients taking long term anti-microbial or anti-inflammatory drugs
- Patients unable to swallow the study capsules, or take 6 of these capsules a day
- Patients unable to provide informed consent
- Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils) or have taken them within 1-month of the study
- Shows unwillingness, inability or lack of motivation to carry out the study procedures or is not prepared to give written consent or to refrain from using other oral hygiene products (mouthwashes, chewing gum, water piks etc.) or to undergo professional dental cleaning for the duration of the study (other than as part of this protocol)
- Antibiotic or anti-inflammatory therapy currently or in previous two weeks
- Current orthodontic treatment
- Currently participating in another Dental Trial
- Diabetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Birmingham Community Healthcare NHSlead
- University of Wuerzburgcollaborator
- Academic Centre for Dentistry in Amsterdamcollaborator
Study Sites (3)
University of Wuerzburg
Würzburg, D-97070, Germany
Academic Centre for Dentistry
Amsterdam, 1066 EA, Netherlands
Birmingham Dental Hospital & School
Birmingham, West Midlands, B4 6NN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iain L Chapple, BDS, PhD
University of Birmingham
- PRINCIPAL INVESTIGATOR
Ulrich Schlagenhauf, PhD
University of Wuerzburg
- PRINCIPAL INVESTIGATOR
Ubele Van der Velden, PhD
Academic Centre for Dentistry in Amsterdam
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor (PI to study)
Study Record Dates
First Submitted
October 26, 2010
First Posted
October 28, 2010
Study Start
May 22, 2017
Primary Completion
June 30, 2017
Study Completion
September 27, 2017
Last Updated
March 18, 2019
Record last verified: 2019-03